← Leaderboards
Raul Jaime Gazmuri
Edward Hines Jr Va Hospital
$1,142,000
Attributed
$1,142,000
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $273K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,142,000 · 1
VA$0 · 3
By mechanism
R01$1,142,000 · 1
I01$0 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ventricular”
- Judith S Hochman · New York University School Of Medicine$113,079,687
- Leonardo Trasande · New York University School Of Medicine$53,629,363
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$33,882,978
- Henry R Halperin · Johns Hopkins University$31,652,891
- Dan M Roden · Vanderbilt University Medical Center$27,757,853
- Robert H Jones · Duke University$27,263,568
Research focus
VentricularAffectMyocardiumTissuesHeart ArrestCardiacMediatingMyocardialCellsSignal TransductionVentricular FibrillationVeteransCardiopulmonary ResuscitationOrganIschemiaLeftDesignMitochondriaBloodHeart FailureHemodynamicsCholesterolAdultChest
Grant awards (16)
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival$0
I01 · FY2025 · VA · contact PI
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival$0
I01 · FY2024 · VA · contact PI
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival$0
I01 · FY2023 · VA · contact PI
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival$0
I01 · FY2022 · VA · contact PI
Cyclophilin-D: A Regulator of Mitochondrial Oxidative Phosphorylation$0
I01 · FY2021 · VA · contact PI
Cyclophilin-D: A Regulator of Mitochondrial Oxidative Phosphorylation$0
I01 · FY2020 · VA · contact PI
Cyclophilin-D: A Regulator of Mitochondrial Oxidative Phosphorylation$0
I01 · FY2019 · VA · contact PI
Cyclophilin-D: A Regulator of Mitochondrial Oxidative Phosphorylation$0
I01 · FY2018 · VA · contact PI
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest$0
I01 · FY2013 · VA · contact PI
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest$0
I01 · FY2012 · VA · contact PI
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest$0
I01 · FY2011 · VA · contact PI
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest$0
I01 · FY2011 · VA · contact PI
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION$273,000
R01 · FY2005 · HL
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION$273,000
R01 · FY2004 · HL
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION$273,000
R01 · FY2003 · HL
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION$323,000
R01 · FY2002 · HL